Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial

Wegovy's heart benefits due to more than weight loss, Novo says

Trump’s Bet in Iowa, Wegovy Study: Your Saturday US Briefing

Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease

Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits

Novo to Build $6 Billion Plant as Obesity Drug Demand Surges

Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals

Weight-loss drug maker Novo Nordisk invests $6 billion to boost output

Astra Enters Obesity Drug Race With Chinese Biotech Deal

New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper

Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic

European Stocks On Track for Best Run Since July on Fed Optimism